Comparison between Idea Cellular IPO and SMS Pharmaceuticals IPO.
Idea Cellular IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while SMS Pharmaceuticals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Idea Cellular IPO is up to ₹2,443.75 Cr whereas the issue size of the SMS Pharmaceuticals IPO is up to ₹98.01 Cr. The final issue price of Idea Cellular IPO is ₹75.00 per share and of SMS Pharmaceuticals IPO is ₹380.00 per share.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹360.00 per share |
| Issue Price (Upper) | ₹75.00 per share | ₹380.00 per share |
| Issue Price (Final) | ₹75.00 per share | ₹380.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 90 shares | 15 shares |
| Fresh Issue Size | 32,58,33,333 shares | 25,79,225 shares |
| Fresh Issue Size (Amount) | up to ₹2,443.75 Cr | up to ₹98.01 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 32,58,33,333 shares | 25,79,225 shares |
| Issue Size Total (Amount) | up to ₹2,443.75 Cr | up to ₹98.01 Cr |
Idea Cellular IPO opens on Feb 12, 2007, while SMS Pharmaceuticals IPO opens on Feb 05, 2007. The closing date of Idea Cellular IPO and SMS Pharmaceuticals IPO is Feb 15, 2007, and Feb 08, 2007, respectively.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 12, 2007 | Feb 05, 2007 |
| Issue Close | Feb 15, 2007 | Feb 08, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Mar 09, 2007 | Feb 28, 2007 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Idea Cellular IPO P/E ratio is , as compared to SMS Pharmaceuticals IPO P/E ratio of .
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 65.8 | 72.31 | ||||
| Promoter Shareholding (Post-Issue) | 58.6 | 53.68 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹19765.20 Cr. | ₹380.00 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 18.08 | 17.41 |
In the Idea Cellular IPO Retail Individual Investors (RII) are offered 9,57,50,000 shares while in SMS Pharmaceuticals IPO retail investors are offered 9,57,50,000 shares. Qualified Institutional Buyers (QIB) are offered 19,15,00,000 shares in Idea Cellular IPO and 12,88,500 shares in SMS Pharmaceuticals IPO.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 19,15,00,000 shares | 12,88,500 shares |
| NII | 3,19,16,667 shares | 3,86,550 shares |
| RII | 9,57,50,000 shares | 9,01,950 shares |
| Employee | 66,66,666 shares | |
| Others | ||
| Total | 32,58,33,333 shares | 25,77,000 shares |
Idea Cellular IPO subscribed 49.66x in total, whereas SMS Pharmaceuticals IPO subscribed 2.64x.
| Idea Cellular IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 78.68x | 3.47x |
| NII (times) | 22.82x | 0.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.87x | 2.47x |
| Employee (times) | 2.25x | |
| Other (times) | ||
| Total (times) | 49.66x | 2.64x |
